Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 4
1959 5
1960 40
1961 70
1962 90
1963 132
1964 134
1965 70
1966 60
1967 67
1968 79
1969 107
1970 107
1971 117
1972 130
1973 152
1974 145
1975 125
1976 142
1977 142
1978 122
1979 124
1980 112
1981 115
1982 90
1983 101
1984 122
1985 89
1986 92
1987 91
1988 94
1989 74
1990 92
1991 80
1992 85
1993 77
1994 104
1995 68
1996 68
1997 83
1998 92
1999 98
2000 158
2001 165
2002 197
2003 263
2004 238
2005 310
2006 275
2007 252
2008 239
2009 279
2010 286
2011 289
2012 327
2013 337
2014 295
2015 297
2016 342
2017 299
2018 305
2019 312
2020 334
2021 338
2022 290
2023 298
2024 336
2025 195

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,463 results

Results by year

Filters applied: . Clear all
Page 1
Spironolactone.
Carone L, Oxberry SG, Twycross R, Charlesworth S, Mihalyo M, Wilcock A. Carone L, et al. J Pain Symptom Manage. 2017 Feb;53(2):288-292. doi: 10.1016/j.jpainsymman.2016.12.320. Epub 2016 Dec 23. J Pain Symptom Manage. 2017. PMID: 28024992 Free article. Review.
A comparison of the aldosterone-blocking agents eplerenone and spironolactone.
Struthers A, Krum H, Williams GH. Struthers A, et al. Clin Cardiol. 2008 Apr;31(4):153-8. doi: 10.1002/clc.20324. Clin Cardiol. 2008. PMID: 18404673 Free PMC article. Review.
This article reviews the pharmacology, clinical efficacy, and tolerability of the two available blocking agents, spironolactone and eplerenone. A Medline search identified clinical studies assessing spironolactone and eplerenone. ...Pharmacological differences betwe …
This article reviews the pharmacology, clinical efficacy, and tolerability of the two available blocking agents, spironolactone and e …
When to use spironolactone, eplerenone or finerenone in the spectrum of cardiorenal diseases.
Kobayashi M, Girerd N, Zannad F. Kobayashi M, et al. Nephrol Dial Transplant. 2024 Jun 28;39(7):1063-1072. doi: 10.1093/ndt/gfae004. Nephrol Dial Transplant. 2024. PMID: 38192033 Review.
The steroidal mineralocorticoid receptor antagonists (MRAs) spironolactone and eplerenone have demonstrated efficacy in improving patient outcomes in cases of heart failure with reduced ejection fraction or after a myocardial infarction, but have limited value in patients …
The steroidal mineralocorticoid receptor antagonists (MRAs) spironolactone and eplerenone have demonstrated efficacy in improving pat …
Spironolactone for hypertension.
Batterink J, Stabler SN, Tejani AM, Fowkes CT. Batterink J, et al. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD008169. doi: 10.1002/14651858.CD008169.pub2. Cochrane Database Syst Rev. 2010. PMID: 20687095
OBJECTIVES: Primary: to determine the effect of spironolactone on patient mortality, morbidity, and to quantify the magnitude of blood pressure lowering effect of spironolactone monotherapy.Secondary: to determine the prevalence of adverse reactions observed with …
OBJECTIVES: Primary: to determine the effect of spironolactone on patient mortality, morbidity, and to quantify the magnitude of bloo …
Spironolactone: a re-examination.
Skluth HA, Gums JG. Skluth HA, et al. DICP. 1990 Jan;24(1):52-9. doi: 10.1177/106002809002400112. DICP. 1990. PMID: 2405587 Review.
A review of the aldosterone antagonist spironolactone is presented. It is effective both as monotherapy and in combination with other hypotensive agents in the control of both essential and hyperaldosterone-induced hypertension. It is useful as a diuretic in conditions suc …
A review of the aldosterone antagonist spironolactone is presented. It is effective both as monotherapy and in combination with other …
Spironolactone.
Ochs HR, Greenblatt DJ, Bodem G, Smith TW. Ochs HR, et al. Am Heart J. 1978 Sep;96(3):389-400. doi: 10.1016/0002-8703(78)90052-2. Am Heart J. 1978. PMID: 356569 Review. No abstract available.
Eplerenone: cardiovascular protection.
Brown NJ. Brown NJ. Circulation. 2003 May 20;107(19):2512-8. doi: 10.1161/01.CIR.0000071081.35693.9A. Circulation. 2003. PMID: 12756192 Review.
However, although aldosterone receptor antagonism reduces mortality in patients with congestive heart failure, the progestational and antiandrogenic side effects of the nonspecific aldosterone receptor antagonist, spironolactone, have limited its usefulness in the treatmen …
However, although aldosterone receptor antagonism reduces mortality in patients with congestive heart failure, the progestational and antian …
Eplerenone (Inspra).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2003 May 12;45(1156):39-40. Med Lett Drugs Ther. 2003. PMID: 12736599 No abstract available.
10,463 results
You have reached the last available page of results. Please see the User Guide for more information.